Holen Sie sich die Stockscreener-App
374.02
2.62%
9.55
Handel nachbörslich:
374.69
0.67
+0.18%
Schlusskurs vom Vortag:
$364.47
Offen:
$363.42
24-Stunden-Volumen:
489.86K
Relative Volume:
1.33
Marktkapitalisierung:
$14.47B
Einnahmen:
$3.26B
Nettoeinkommen (Verlust:
$503.61M
KGV:
34.02
EPS:
10.9949
Netto-Cashflow:
$718.54M
1W Leistung:
+8.84%
1M Leistung:
+12.76%
6M Leistung:
+30.09%
1J Leistung:
+34.12%
1-Tages-Spanne:
$356.19
$375.51
1-Wochen-Bereich:
$338.95
$375.51
52-Wochen-Spanne:
$148.63
$375.51
Evercore Inc Stock (EVR) Company Profile
Firmenname
Evercore Inc
Sektor
Branche
Telefon
212-857-3100
Adresse
55 EAST 52ND STREET, NEW YORK, NY
Vergleichen Sie EVR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
374.02 | 14.10B | 3.26B | 503.61M | 718.54M | 10.99 |
|
MS
Morgan Stanley
|
187.75 | 296.47B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
955.47 | 284.46B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
103.57 | 184.34B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
121.70 | 110.82B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
IBKR
Interactive Brokers Group Inc
|
72.88 | 31.87B | 10.12B | 4.13B | 27.25B | 2.0757 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-09 | Eingeleitet | Deutsche Bank | Buy |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-06-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-04-08 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-20 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-11 | Hochstufung | Goldman | Neutral → Buy |
| 2024-01-29 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2024-01-09 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-22 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-12 | Hochstufung | UBS | Sell → Buy |
| 2023-01-11 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-09-23 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-09 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-03-19 | Bestätigt | Goldman | Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-12-16 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-12-01 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-08-05 | Hochstufung | Goldman | Neutral → Buy |
| 2020-07-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-06 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-14 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-05-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2018-11-06 | Eingeleitet | Goldman | Neutral |
| 2018-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2017-05-23 | Herabstufung | Goldman | Buy → Neutral |
| 2017-03-27 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2017-02-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-02-13 | Herabstufung | Instinet | Buy → Neutral |
| 2016-12-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2016-11-21 | Fortgesetzt | Credit Suisse | Outperform |
Alle ansehen
Evercore Inc Aktie (EVR) Neueste Nachrichten
SLB raised on reduced risk profile, Halliburton cut on North America exposure at Evercore ISI - Seeking Alpha
UnitedHealth wins outperform at Evercore despite elevated utilization trends - MSN
Canadian Natural Resources (TSE:CNQ) Stock Rating Lowered by Evercore Partners - MarketBeat
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - ts2.tech
Evercore ISI downgrades MetLife, cites rich valuation - TradingView — Track All Markets
Fortrea upgraded at Evercore ISI on new CEO (FTRE:NASDAQ) - Seeking Alpha
Evercore ISI Adjusts Price Target on Fifth Third Bancorp to $52 From $47, Maintains In Line Rating - marketscreener.com
UnitedHealth wins Outperform rating at Evercore ISI (UNH:NYSE) - Seeking Alpha
Evercore ISI Adjusts Price Target on U.S. Bancorp to $60 From $53, Maintains In Line Rating - marketscreener.com
TFC Upgrade: Evercore ISI Group Raises Price Target to $58 | TFC Stock News - GuruFocus
Zions Bancorporation, N.A. (NASDAQ:ZION) Receives In-Line Rating from Evercore ISI - MarketBeat
Truist Financial (NYSE:TFC) Upgraded to Outperform at Evercore ISI - MarketBeat
MTB Stock Sees Downgrade and Raised Price Target by Evercore ISI - GuruFocus
ALLY Stock Upgraded to Outperform by Evercore ISI Group | ALLY S - GuruFocus
BP Downgraded by Evercore ISI Group to In-Line Rating | BP Stock News - GuruFocus
Pinnacle Financial Partners (NASDAQ:PNFP) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI Upgrades Ally Financial (ALLY) Amid Positive Outloo - GuruFocus
Evercore ISI shifts oil stock ratings as SLB upgraded and peers cut - Investing.com Canada
Ally Financial, Truist upgraded, M&T Bank, Zions, Regions cut at Evercore (ALLY:NYSE) - Seeking Alpha
Evercore ISI Adjusts Price Target on Wells Fargo to $110 From $107 - marketscreener.com
Evercore ISI Adjusts Price Target on Citizens Financial Group to $69 From $60, Maintains Outperform Rating - marketscreener.com
Evercore ISI initiates Pinnacle Financial with Buy-equivalent post Synovus acquisition (PNFP:NYSE) - Seeking Alpha
KeyCorp (NYSE:KEY) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
Evercore ISI Adjusts Price Target on Capital One Financial to $290 From $255, Maintains Outperform Rating - marketscreener.com
Baxter International (NYSE:BAX) Given New $23.00 Price Target at Evercore ISI - MarketBeat
Abbott Laboratories (NYSE:ABT) Given New $144.00 Price Target at Evercore ISI - MarketBeat
Evercore ISI Adjusts Price Target on Synchrony Financial to $97 From $86, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on American Express to $400 From $385, Maintains In Line Rating - marketscreener.com
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes - Investing.com UK
Canadian Natural Resources (NYSE:CNQ) Rating Lowered to In-Line at Evercore ISI - MarketBeat
Globe Life (NYSE:GL) Lowered to In-Line Rating by Evercore ISI - MarketBeat
Ally Financial (NYSE:ALLY) Upgraded at Evercore ISI - MarketBeat
Evercore ISI Upgrades Jackson Financial Incorporation to In Line From Underperform, Adjusts Price Target to $118 From $110 - marketscreener.com
Evercore ISI Upgrades Fortrea Holdings to Outperform From In Line, Adjusts Price Target to $25 From $14 - marketscreener.com
Bausch + Lomb (NYSE:BLCO) Rating Lowered to "Hold" at Evercore ISI - MarketBeat
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Exact Sciences (NASDAQ:EXAS) Stock Rating Lowered by Evercore ISI - MarketBeat
Evercore ISI Downgrades M&T Bank to In Line From Outperform, Adjusts Price Target to $225 From $210 - marketscreener.com
Evercore ISI Downgrades Regions Financial to Underperform From In Line, Raises Price Target to $29 From $27 - marketscreener.com
Evercore ISI Upgrades Truist Financial to Outperform From In Line, Adjusts Price Target to $58 From $49 - marketscreener.com
Insurer Globe Life falls after Evercore ISI downgrades rating - TradingView — Track All Markets
Evercore ISI upgrades Ally Financial stock rating to Outperform By Investing.com - Investing.com UK
Evercore ISI Adjusts Price Target on Boston Scientific to $112 From $113, Maintains Outperform Rating - marketscreener.com
Evercore ISI Upgrades Agilent Technologies to Outperform From In Line, Adjusts PT to $160 From $155 - marketscreener.com
Evercore ISI initiates Pinnacle Financial stock with Outperform rating By Investing.com - Investing.com India
UnitedHealth Group stock rating initiated at Outperform by Evercore ISI - Investing.com India
Evercore ISI upgrades Fortrea stock to Outperform on biopharma cycle By Investing.com - Investing.com UK
Evercore ISI downgrades BP stock to In Line on CEO transition concerns - Investing.com Canada
Evercore ISI initiates Pinnacle Financial stock with Outperform rating - Investing.com
Evercore ISI downgrades Halliburton stock rating to In Line on valuation - Investing.com UK
Finanzdaten der Evercore Inc-Aktie (EVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):